Histone deacetylase inhibitors suppress IL-2-mediated gene expression prior to induction of apoptosis

Citation
Y. Koyama et al., Histone deacetylase inhibitors suppress IL-2-mediated gene expression prior to induction of apoptosis, BLOOD, 96(4), 2000, pp. 1490-1495
Citations number
38
Categorie Soggetti
Hematology,"Cardiovascular & Hematology Research
Journal title
BLOOD
ISSN journal
00064971 → ACNP
Volume
96
Issue
4
Year of publication
2000
Pages
1490 - 1495
Database
ISI
SICI code
0006-4971(20000815)96:4<1490:HDISIG>2.0.ZU;2-U
Abstract
Histone deacetylase (HDAC) inhibitors can induce transcriptional activation of a number of genes and induce cellular differentiation as histone acetyl ation levels increase. Although these inhibitors induce apoptosis in severa l cell lines, the precise mechanism by which they do so remains obscure. Th is study shows that HDAC inhibitors, sodium butyrate and trichostatin A (TS A), abrogate interleukin (IL)-2-mediated gene expression in IL-2-dependent cells. The HDAC inhibitors readily induced apoptosis in IL-2-dependent ILT- Mat cells and BAF-B03 transfectants expressing the IL-2 receptor beta c cha in, whereas they induced far less apoptosis in cytokine-independent K562 ce lls. However, these inhibitors similarly increased acetylation levels of hi stones in both cells. Although histone hyperacetylation is believed to lead to transcriptional activation, the results showed an abrogation of IL-2-me diated induction of c-myc, bag-1, and LC-PTP gene expression. This observed abrogation of gene expression occurred prior to phosphatidylserine externa lization, a process that occurs in early apoptotic cells. Considering the b iologic role played by IL-2-mediated gene expression in cell survival, thes e data suggest that its abrogation may contribute to the apoptotic process induced by HDAC inhibitors. (Blood. 2000;96:1490-1495) (C) 2000 by The Amer ican Society of Hematology.